Table 1.
Description of included studies
| No. studies | No. patients (total 451) | Response rate CR + PR, %(95% CI) | |
|---|---|---|---|
| Size of study (n patients) | |||
| 5–25 | 5 | 82 | 50 (39–61) |
| 26–46 | 4 | 136 | 48 (40–56) |
| 47–120 | 3 | 233 | 44 (38–51) |
| Thalidomide starting dose | |||
| 100 | 5 | 250 | 40 (35–47) |
| 200 | 5 | 165 | 52 (45–60) |
| 400 | 1 | 6 | 83 (44–97) |
| Thalidomide target dose | |||
| 100 | 1 | 120 | 52 (43–60) |
| 200 | 4 | 156 | 42 (35–50) |
| 300/400 | 4 | 84 | 64 (54–74) |
| 600/800 | 3 | 91 | 40 (30–50) |
| Dexamethasone cumulative dose in first month | |||
| <200 mg | 6 | 259 | 45 (39–51) |
| 200–320 mg | 4 | 101 | 47 (37–56) |
| >400 mg | 2 | 91 | 51 (41–61) |
Only 11 studies stated a starting dose.